Home » Newsletters » BioWorld Science

BioWorld Science

June 28, 2000

View Archived Issues

Estrogen fails to alter cognition, mood or cerebral blood flow in Alzheimer's patients

Disulfiram plus buprenorphine curbs cocaine use in dual opioid/cocaine-dependent subjects

Aventis and Millennium establish alliance for antiinflammatory drugs and drug discovery technologies

Lorus Therapeutics reports strong meta-analysis results for Virulizin, prepares for phase III trials

Celsion submits IND for phase II trials of BPH treatment

COX-2 identified as new therapeutic target for type 1 diabetes

FDA completes initial review of BLA for Campath

StressGen's HspE7 advances to phase III trials in anal dysplasia

Cholinergic agonist for Sjogren's syndrome introduced in U.S.

Takeda's angiogenesis inhibitor TNP-470 shows additional potential in rheumatoid arthritis

ENDO 2000 news: U.S. researchers characterize potent new antiprogestational agent

Further details on pharmacological profile of FE-200486 presented at ENDO 2000

SM-31900 emerges as a promising therapeutic for stroke

Endogenous pulsatile GH secretion, plasma IGF-I levels stimulated by low-dose NN-703

JTT-608 stimulates GLP-1 secretion from the intestine, similar to glucose

AndroGel now available in U.S. to treat men with hypogonadism

Apoptosis-inducing small molecule targeting Bcl-2 recently identified

Insmed completes acquisition of Celtrix; now has two product candidates in phase II

New Pfizer compounds with selectivity for certain MMPs and TACE

Compounds with urethra-selective contractile activity in development for urinary incontinence

Roche presents 4-aroylpiperidines active as chemokine receptor antagonists

BASF joins in search for therapeutically useful PARP inhibitors

Novel kininogen-derived antiangiogenic peptides emerge from joint research program

Human parvovirus-containing vaccines for rheumatoid arthritis

Riluzole + alpha-tocopherol delays progression of ALS more frequently than riluzole alone

Use of seratrodast for COPD supported by clinical results

Baxter completes acquisition of North American Vaccine

United Therapeutics discontinues UT-77 development project

Cytogen seeks European approval of ProstaScint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...